TABLE 2.
ADE-positive rates in IgG-positive sera of COVID-19 acute and convalescent patients
| Group | FcγR | C1q | FcγR and C1q | FcγR and/or C1q |
|---|---|---|---|---|
| Convalescent | 57.1% (12/21) | 57.1% (12/21) | 52.4% (11/21) | 61.9 (13/21) |
| Mild disease | 12.5% (1/8) | 50% (4/8) | 12.5% (1/8) | 50.0% (4/8) |
| Moderate disease | 7.7% (1/13) | 38.5% (5/13) | 7.7% (1/13) | 38.5% (5/13) |
| Severe disease | 25% (2/8) | 25% (2/8) | 12.5% (1/8) | 37.5 (3/8) |
| All acute patients | 13.8% (4/29) | 37.9% (11/29) | 10.3% (3/29) | 41.4 (12/29) |
| Total | 32% (16/50) | 46% (23/50) | 28% (14/50) | 50% (25/50) |